Vaccine-associated Rubella - a report of two cases and a review of the literature

Hum Vaccin Immunother. 2021 Jan 2;17(1):224-227. doi: 10.1080/21645515.2020.1765623. Epub 2020 Jun 12.

Abstract

We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully. One patient was confirmed to have vaccine-associated rubella via sequencing of virus isolated in viral culture. The other patient had a pharyngeal swab positive for rubella virus PCR, with sequencing matching the vaccine strain. There are few reports of clinical disease from rubella vaccine-strains in the literature. Previous authors have reported severe disseminated vaccine-associated rubella in both immunodeficient and immunocompetent patients. Further study is required to ascertain the incidence, risk factors, and clinical characteristics of this condition; as well as investigate the extent of horizontal transmission to guide infection control recommendations.

Keywords: MMR; Rubella; genotyping; vaccine; vaccine strain.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antibodies, Viral
  • Humans
  • Infant
  • Measles*
  • Measles-Mumps-Rubella Vaccine / adverse effects
  • Mumps*
  • Rubella Vaccine / adverse effects
  • Rubella* / prevention & control
  • Vaccination

Substances

  • Antibodies, Viral
  • Measles-Mumps-Rubella Vaccine
  • Rubella Vaccine

Grants and funding

No funding was needed in the preparation of this manuscript.